Given that CBLB502 is a potent activator of the NF-κB signaling in 4T1 carcinoma cells (Fig. 1b, d), we tested whether CBLB502 was sufficient to elicit stimulatory changes in the 4T1 cell cytokine profile. This evidence concerns the gene NFKB1 and carcinoma.